US Stock MarketDetailed Quotes

MCRB Seres Therapeutics

Watchlist
  • 0.909
  • +0.084+10.18%
Close Apr 29 16:00 ET
  • 0.919
  • +0.010+1.11%
Post 16:26 ET
137.27MMarket Cap-1021P/E (TTM)

Seres Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
48.71%-117.35M
10.20%-47.5M
0.55%-59.26M
232.24%65.98M
-15.26%-76.58M
-3,521.29%-228.82M
-1.98%-52.89M
-146.64%-59.58M
-25.70%-49.9M
-125.27%-66.45M
Net income from continuing operations
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
-187.96%-60M
-33.94%-64.74M
-59.66%-56.62M
Operating gains losses
--71K
---410K
---1.01M
----
----
----
----
----
----
----
Depreciation and amortization
-5.82%6.24M
0.31%1.63M
-3.61%1.68M
-9.38%1.53M
-10.83%1.4M
11.47%6.63M
4.83%1.63M
17.01%1.75M
18.16%1.69M
6.37%1.57M
Other non cash items
118.78%15.17M
14.30%2.83M
-19.30%2.04M
158.79%4.43M
2,627.44%5.86M
70.39%6.93M
-2.37%2.48M
1,561.85%2.53M
83.60%1.71M
-72.19%215K
Change In working capital
-220.68%-58.98M
-442.13%-15.39M
-120.19%-22.79M
-132.84%-1.46M
-13.76%-19.34M
-144.28%-18.39M
144.87%4.5M
-119.96%-10.35M
852.56%4.46M
-2,151.39%-17M
-Change in receivables
---8.67M
--8.18M
---9.3M
----
----
--0
--0
--0
----
----
-Change in inventory
---29.65M
---11.12M
---13.19M
----
----
--0
--0
--0
----
----
-Change in prepaid assets
-131.16%-29.12M
-10,642.67%-31.63M
60.97%-1.08M
108.49%535K
179.25%3.04M
-2.12%-12.6M
104.09%300K
-93.67%-2.75M
-189.57%-6.3M
-173.97%-3.84M
-Change in payables and accrued expense
-23.09%4.26M
267.81%21.54M
-63.31%-4.51M
-20.12%10.07M
-124.83%-22.84M
-89.43%5.54M
26.04%5.86M
-106.63%-2.76M
98.91%12.6M
-3,867.58%-10.16M
-Change in other current liabilities
47.73%-2.2M
17.72%-562K
23.88%-1.06M
18.14%-510K
95.55%-67K
-18.39%-4.2M
49.96%-683K
-18.50%-1.39M
-383.18%-623K
-22.32%-1.51M
-Change in other working capital
189.86%6.41M
-84.51%-1.8M
284.03%6.34M
210.53%1.34M
134.96%522K
-63.60%-7.13M
86.50%-975K
-126.96%-3.44M
76.90%-1.22M
67.88%-1.49M
Cash from discontinued investing activities
Operating cash flow
48.71%-117.35M
10.20%-47.5M
0.55%-59.26M
232.24%65.98M
-15.26%-76.58M
-3,521.29%-228.82M
-1.98%-52.89M
-146.64%-59.58M
-25.70%-49.9M
-125.27%-66.45M
Investing cash flow
Cash flow from continuing investing activities
-87.16%10.58M
-114.80%-877K
-104.48%-1.8M
-55.05%10.52M
-78.89%2.74M
28.62%82.43M
-55.06%5.93M
59.81%40.13M
-49.71%23.4M
162.55%12.97M
Net PPE purchase and sale
18.80%-7.98M
74.66%-877K
-44.11%-1.8M
43.00%-1.23M
-37.90%-4.07M
-2.67%-9.82M
-119.33%-3.46M
69.53%-1.25M
15.31%-2.16M
-119.82%-2.95M
Net investment purchase and sale
-79.88%18.56M
--0
--0
-54.03%11.75M
-57.25%6.81M
25.25%92.25M
-33.02%9.39M
41.69%41.38M
-48.70%25.56M
182.09%15.92M
Cash from discontinued investing activities
Investing cash flow
-87.16%10.58M
-114.80%-877K
-104.48%-1.8M
-55.05%10.52M
-78.89%2.74M
28.62%82.43M
-55.06%5.93M
59.81%40.13M
-49.71%23.4M
162.55%12.97M
Financing cash flow
Cash flow from continuing financing activities
-44.67%71.71M
39.85%6.43M
-98.53%1.44M
44,651.54%58.18M
-78.93%5.66M
10,901.87%129.6M
689.36%4.6M
15,996.39%98.03M
-77.78%130K
3,414.14%26.85M
Net issuance payments of debt
96.58%50.52M
--0
--0
--50.52M
--0
2,810.86%25.7M
--0
--0
--0
--25.7M
Net common stock issuance
-82.05%18.16M
450.43%6.43M
--0
--7.49M
--4.24M
--101.17M
--1.17M
--100M
--0
--0
Proceeds from stock option exercised by employees
10.71%3.03M
--0
10.49%1.44M
29.23%168K
23.32%1.42M
28.65%2.74M
-10.71%150K
114.45%1.31M
-77.78%130K
50.39%1.15M
Cash from discontinued financing activities
Financing cash flow
-44.67%71.71M
39.85%6.43M
-98.53%1.44M
44,651.54%58.18M
-78.93%5.66M
10,901.87%129.6M
689.36%4.6M
15,996.39%98.03M
-77.78%130K
3,414.14%26.85M
Net cash flow
Beginning cash position
-8.93%171.22M
-16.61%178.1M
76.07%237.71M
-36.16%103.03M
-8.93%171.22M
62.00%188M
-6.10%213.58M
82.45%135.01M
142.38%161.38M
62.00%188M
Current changes in cash
-108.91%-35.07M
1.00%-41.95M
-175.86%-59.61M
610.76%134.68M
-156.11%-68.19M
-123.33%-16.79M
-7.38%-42.37M
-48.80%78.58M
-455.46%-26.37M
46.18%-26.63M
Effect of exchange rate changes
300.00%2K
--0
150.00%1K
----
----
0.00%-1K
200.00%1K
---2K
----
----
End cash Position
-20.48%136.15M
-20.48%136.15M
-16.61%178.1M
76.07%237.71M
-36.16%103.03M
-8.93%171.22M
-8.93%171.22M
-6.10%213.58M
82.45%135.01M
142.38%161.38M
Free cash flow
47.48%-125.33M
14.16%-48.38M
-0.37%-61.05M
224.38%64.75M
-16.22%-80.65M
-8,191.77%-238.64M
-5.45%-56.35M
-149.19%-60.83M
-23.22%-52.06M
-125.03%-69.4M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 48.71%-117.35M10.20%-47.5M0.55%-59.26M232.24%65.98M-15.26%-76.58M-3,521.29%-228.82M-1.98%-52.89M-146.64%-59.58M-25.70%-49.9M-125.27%-66.45M
Net income from continuing operations 54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M-187.96%-60M-33.94%-64.74M-59.66%-56.62M
Operating gains losses --71K---410K---1.01M----------------------------
Depreciation and amortization -5.82%6.24M0.31%1.63M-3.61%1.68M-9.38%1.53M-10.83%1.4M11.47%6.63M4.83%1.63M17.01%1.75M18.16%1.69M6.37%1.57M
Other non cash items 118.78%15.17M14.30%2.83M-19.30%2.04M158.79%4.43M2,627.44%5.86M70.39%6.93M-2.37%2.48M1,561.85%2.53M83.60%1.71M-72.19%215K
Change In working capital -220.68%-58.98M-442.13%-15.39M-120.19%-22.79M-132.84%-1.46M-13.76%-19.34M-144.28%-18.39M144.87%4.5M-119.96%-10.35M852.56%4.46M-2,151.39%-17M
-Change in receivables ---8.67M--8.18M---9.3M----------0--0--0--------
-Change in inventory ---29.65M---11.12M---13.19M----------0--0--0--------
-Change in prepaid assets -131.16%-29.12M-10,642.67%-31.63M60.97%-1.08M108.49%535K179.25%3.04M-2.12%-12.6M104.09%300K-93.67%-2.75M-189.57%-6.3M-173.97%-3.84M
-Change in payables and accrued expense -23.09%4.26M267.81%21.54M-63.31%-4.51M-20.12%10.07M-124.83%-22.84M-89.43%5.54M26.04%5.86M-106.63%-2.76M98.91%12.6M-3,867.58%-10.16M
-Change in other current liabilities 47.73%-2.2M17.72%-562K23.88%-1.06M18.14%-510K95.55%-67K-18.39%-4.2M49.96%-683K-18.50%-1.39M-383.18%-623K-22.32%-1.51M
-Change in other working capital 189.86%6.41M-84.51%-1.8M284.03%6.34M210.53%1.34M134.96%522K-63.60%-7.13M86.50%-975K-126.96%-3.44M76.90%-1.22M67.88%-1.49M
Cash from discontinued investing activities
Operating cash flow 48.71%-117.35M10.20%-47.5M0.55%-59.26M232.24%65.98M-15.26%-76.58M-3,521.29%-228.82M-1.98%-52.89M-146.64%-59.58M-25.70%-49.9M-125.27%-66.45M
Investing cash flow
Cash flow from continuing investing activities -87.16%10.58M-114.80%-877K-104.48%-1.8M-55.05%10.52M-78.89%2.74M28.62%82.43M-55.06%5.93M59.81%40.13M-49.71%23.4M162.55%12.97M
Net PPE purchase and sale 18.80%-7.98M74.66%-877K-44.11%-1.8M43.00%-1.23M-37.90%-4.07M-2.67%-9.82M-119.33%-3.46M69.53%-1.25M15.31%-2.16M-119.82%-2.95M
Net investment purchase and sale -79.88%18.56M--0--0-54.03%11.75M-57.25%6.81M25.25%92.25M-33.02%9.39M41.69%41.38M-48.70%25.56M182.09%15.92M
Cash from discontinued investing activities
Investing cash flow -87.16%10.58M-114.80%-877K-104.48%-1.8M-55.05%10.52M-78.89%2.74M28.62%82.43M-55.06%5.93M59.81%40.13M-49.71%23.4M162.55%12.97M
Financing cash flow
Cash flow from continuing financing activities -44.67%71.71M39.85%6.43M-98.53%1.44M44,651.54%58.18M-78.93%5.66M10,901.87%129.6M689.36%4.6M15,996.39%98.03M-77.78%130K3,414.14%26.85M
Net issuance payments of debt 96.58%50.52M--0--0--50.52M--02,810.86%25.7M--0--0--0--25.7M
Net common stock issuance -82.05%18.16M450.43%6.43M--0--7.49M--4.24M--101.17M--1.17M--100M--0--0
Proceeds from stock option exercised by employees 10.71%3.03M--010.49%1.44M29.23%168K23.32%1.42M28.65%2.74M-10.71%150K114.45%1.31M-77.78%130K50.39%1.15M
Cash from discontinued financing activities
Financing cash flow -44.67%71.71M39.85%6.43M-98.53%1.44M44,651.54%58.18M-78.93%5.66M10,901.87%129.6M689.36%4.6M15,996.39%98.03M-77.78%130K3,414.14%26.85M
Net cash flow
Beginning cash position -8.93%171.22M-16.61%178.1M76.07%237.71M-36.16%103.03M-8.93%171.22M62.00%188M-6.10%213.58M82.45%135.01M142.38%161.38M62.00%188M
Current changes in cash -108.91%-35.07M1.00%-41.95M-175.86%-59.61M610.76%134.68M-156.11%-68.19M-123.33%-16.79M-7.38%-42.37M-48.80%78.58M-455.46%-26.37M46.18%-26.63M
Effect of exchange rate changes 300.00%2K--0150.00%1K--------0.00%-1K200.00%1K---2K--------
End cash Position -20.48%136.15M-20.48%136.15M-16.61%178.1M76.07%237.71M-36.16%103.03M-8.93%171.22M-8.93%171.22M-6.10%213.58M82.45%135.01M142.38%161.38M
Free cash flow 47.48%-125.33M14.16%-48.38M-0.37%-61.05M224.38%64.75M-16.22%-80.65M-8,191.77%-238.64M-5.45%-56.35M-149.19%-60.83M-23.22%-52.06M-125.03%-69.4M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-3.20%